ST
STLE
STEELE BANCORP INC
$41.65
+0.36%
No data for this timeframe.
Vol
SEC Reports6
Recent Activity
May 21, 2026
SEC
Steele Bancorp declared a regular semi-annual cash dividend of $0.76 per share for H1 2026, payable June 29 to holders o
8-K — Impact 2/10
May 12, 2026
SEC
Steele Bancorp filed an 8-K reporting results of its 2026 Annual Meeting of Shareholders, where all four director nomine
8-K — Impact 2/10
May 11, 2026
SEC
Steele Bancorp filed Amendment No. 1 to its 2025 Form 10-K solely to correct a labeling error — removing the word '(Unau
10-K/A — Impact 2/10
Latest Reports
NEUTRAL
8-K
2/10
Steele Bancorp declared a regular semi-annual cash dividend of $0.76 per share for H1 2026, payable June 29 to holders o
May 21, 2026
NEUTRAL
8-K
2/10
Steele Bancorp filed an 8-K reporting results of its 2026 Annual Meeting of Shareholders, where all four director nomine
May 12, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 2.5/10.
NEUTRAL
8-K
2/10
Steele Bancorp declared a regular semi-annual cash dividend of $0.76 per share for H1 2026, payable
May 21, 2026
NEUTRAL
8-K
2/10
Steele Bancorp filed an 8-K reporting results of its 2026 Annual Meeting of Shareholders, where all
May 12, 2026
NEUTRAL
10-K/A
2/10
Steele Bancorp filed Amendment No. 1 to its 2025 Form 10-K solely to correct a labeling error — remo
May 11, 2026
NEUTRAL
10-Q/A
1/10
Steele Bancorp filed an amended Form 10-Q/A solely to correct an exhibit reference for its Bylaws, c
May 6, 2026
NEUTRAL
10-Q/A
2/10
Steele Bancorp filed an amended 10-Q (Amendment No. 1) solely to correct a reference to its bylaws e
May 6, 2026
BULLISH
8-K
6/10
Steele Bancorp reported first-quarter 2026 earnings with net income of $4.88 million, up 170% year-o
Apr 20, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.